Information regarding Trulance in Canada is limited. However, the drug, known chemically as plecanatide, is used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation in adults [1].
What is Trulance (plecanatide) used for?
Trulance (plecanatide) is a medication prescribed for adults experiencing chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) [1]. It works by increasing fluid secretion in the intestines, which helps to soften stool and promote bowel movements [1].
When did Trulance get approved in Canada?
Specific approval dates for Trulance in Canada were not found in the provided information. The drug has received approval in other regions, such as the United States [1].
Are there any generics or biosimilars for Trulance?
As of the current information, there is no indication of generic or biosimilar versions of Trulance being available or in development. Information on patent expiry dates for Trulance in Canada would be necessary to assess future generic competition [2].
What are the potential side effects of Trulance?
Common side effects associated with Trulance include diarrhea [1]. Patients should consult with their healthcare provider for a comprehensive list of potential side effects and to discuss any concerns.
How does Trulance compare to other IBS-C or CIC treatments?
Trulance belongs to a class of drugs called guanylate cyclase-C (GC-C) agonists. Other medications in this class, such as linaclotide (Constella in Canada), also treat IBS-C and CIC by increasing intestinal fluid and motility [3]. The choice of treatment often depends on individual patient characteristics and medical history.
Where can I find more detailed information about Trulance in Canada?
For detailed prescribing information, including clinical data, approved indications, and potential contraindications for Trulance in Canada, patients and healthcare professionals should refer to the official product monograph and consult with Canadian regulatory bodies and healthcare providers. Information on drug approvals and patents in Canada can often be found through Health Canada and resources like DrugPatentWatch.com [2].
Sources:
1. https://www.drugpatentwatch.com/drugs/trulance
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/drugs/constella